Profound Medical (PROF) Research & Development (2024 - 2026)

Profound Medical's Research & Development history runs 3 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• In Q1 2026, Research & Development rose 9.44% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $21.0 million (up 18.07% YoY), while the FY2025 annual figure was $20.6 million, up 21.4% from the prior year.
• Research & Development was $5.3 million for Q1 2026 at Profound Medical, up from $4.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.1 million in Q2 2025 to a low of $3.9 million in Q1 2024.
• Historically, Research & Development has averaged $4.8 million across 3 years, with a median of $4.6 million in 2024.
• Biggest YoY gain for Research & Development was 45.02% in 2025; the steepest drop was 8.11% in 2025.
• A 3-year view of Research & Development shows it stood at $4.6 million in 2024, then slipped by 8.11% to $4.3 million in 2025, then increased by 23.17% to $5.3 million in 2026.
• The last three Research & Development figures came in at $5.3 million (Q1 2026), $4.3 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.